Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ATAI Life Sciences N.V. - Common Shares (NQ:ATAI)

1.965 +0.125 (+6.79%)
Streaming Delayed Price Updated: 11:28 AM EDT, May 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ATAI Life Sciences N.V. - Common Shares

< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
27 28 Next >
Atai's New MDMA-Based EMP-01 Compound Moves Forward To The Clinical Stage
Atai Life Sciences' (NASDAQ: ATAI) wholly-owned subsidiary EmpathBio has received Medsafe central regulatory and the Health and Disability Ethics Committees (HDEC) approvals to begin participant... 
Via Benzinga
Small Pharma, Revive Therapeutics Among Top Psychedelic Movers Of Today
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 9.91% at $0.13 
Via Benzinga
Psychedelic Stocks Continue To Plummet: -16% This Week; -33% MTD; Now -57% YTD
Look at how the only psychedelic stocks with market caps larger than $50M gave performed this last week. 
Via Talk Markets
Psychedelic Stock Gainers And Losers From September 22, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 2.80% at $1.10 
Via Benzinga
Atlanta Becomes Latest City to Consider Decriminalizing Psychedelics
Atlanta just became the latest city to consider decriminalizing psychedelics. On September 12, just one week after San Francisco officially decriminalized psychedelics, a meeting was held by the City... 
Via PressReach
Atlanta Becomes Latest City to Consider Decriminalizing Psychedelics
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 22, 2022 – Atlanta just became the latest city to consider decriminalizing psychedelics. On September 12, just one... 
Via FinancialNewsMedia
Psychedelic Stock Gainers And Losers From September 21, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 7.87% at $0.32 
Via Benzinga
Seelos Therapeutics, Allied Among Top Psychedelic Movers Of Today
GAINERS: Allied (OTC:ALID) shares closed up 7.83% at $0.62 
Via Benzinga
Psychedelic Stock Gainers And Losers From September 19, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 5.28% at $0.65 
Via Benzinga
The 5 Cannabis Categories Declined Between 3% And 11.5% Last Week
The cannabis sector consists of 5 distinctly different categories and they each perform quite differently. 
Via Talk Markets
8 Largest Psychedelic Stocks Continued Their Decline Last Week
The 8 stocks in the munKNEE Psychedelic Compounds-Based Drug Stocks Index were collectively down 10% in the past week. We also take a look at some therapy-clinic stocks. 
Via Talk Markets
Numinus Wellness, GH Research Among Top Psychedelic Movers Of Today
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 3.98% at $14.64 
Via Benzinga
GH Research, Cybin Among Top Psychedelic Movers Of Today
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 9.26% at $13.81 
Via Benzinga
Great Psychedelics And Business Events Are Coming In Q4: Check Them Out Here
The season for psychedelics conferences is right around the corner. From very large and well-known events to small meets, this year’s remaining months are loaded with on-site and virtual discussions... 
Via Benzinga
Biomind Labs, Allied Among Top Psychedelic Movers Of Today
GAINERS: Biomind Labs (OTC:BMNDF) shares closed up 44.93% at $1.00 
Via Benzinga
8 Largest Psychedelic Stocks Dropped Almost 12% This Week
The 8 stocks in our Psychedelic Compounds-Based Drug Stocks Index, while they gained 18.5% in August, declined 11.6% this week. Also, a look into some clinic stocks. 
Via Talk Markets
Psychedelic Stock Gainers And Losers From September 9, 2022
GAINERS: Allied (OTC:ALID) shares closed up 21.78% at $0.52 
Via Benzinga
Small Pharma, Seelos Therapeutics Among Top Psychedelic Movers Of Today
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 13.39% at $1.27 
Via Benzinga
Psychedelic Stock Gainers And Losers From September 7, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 5.66% at $1.12 
Via Benzinga
Psychedelic Stock Gainers And Losers From September 6, 2022
GAINERS: Numinus Wellness (OTC:NUMIF) shares closed up 11.90% at $0.30 LOSERS: 
Via Benzinga
Cathie Wood's Psychedelics Fund ARK Analyzes The Sector's Present & Future And Likes What It Sees
Cathie Wood’s ARK Genomic Revolution EFT has been making big investments in the psychedelics sector since February 2022, most notably in A 
Via Benzinga
Largest Psychedelic Stocks Up In August; Up 42% Since End Of June
The 8 stocks in our Psychedelic Compounds-Based Drug Stocks Index are on average UP 18.5% in August. 
Via Talk Markets
Small Pharma, Revive Therapeutics Among Top Psychedelic Movers Of Today
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 6.41% at $0.29 
Via Benzinga
Small Pharma, Cybin Among Top Psychedelic Movers Of Today
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 12.57% at $0.27 LOSERS: 
Via Benzinga
Psychedelics Funding At Its Best: $1.5 M Destined To Psilocybin Clinical Trials In Australia
Psychedelics biopharma company Lobe Sciences Ltd. 
Via Benzinga
Psychedelics Use Among Young Adults Reaches All-Time High
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 1, 2022 – Young adults are using more hallucinogens than ever. According to a National Institute of Health survey,... 
Via FinancialNewsMedia
Psychedelic Stock Gainers And Losers From August 31, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 31.95% at $0.24 
Via Benzinga
World Class Leaders In Psychedelics Form Benzinga's Psychedelic Advisory Council—Get To Know Them
The Benzinga Psychedelics Advisory Council was introduced in March of 2022 with the sustained goal of better informing investors and general audience about the psychedelics financial and business... 
Via Benzinga
Compass Pathways, Seelos Therapeutics Among Top Psychedelic Movers Of Today
GAINERS: Cybin (AMEX:CYBN) shares closed up 2.83% at $1.09 LOSERS: 
Via Benzinga
7 Psychedelics Stocks to Buy for a Big Drug Boom
These are the seven psychedelics stocks to buy in September. PSIL, ATAI, CMPS, CYBN, ENVB, GHRS and MNMD can make great investments 
Via InvestorPlace
< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
27 28 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.